Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 21, Issue 3, Pages 247-251
Publisher
Informa UK Limited
Online
2020-01-02
DOI
10.1080/14656566.2019.1702967
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys
- (2019) Jeffrey B. Schwimmer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sex Differences in NAFLD : State of the Art and Identification of Research Gaps
- (2019) Amedeo Lonardo et al. HEPATOLOGY
- Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes
- (2019) Fabio Nascimbeni et al. ATHEROSCLEROSIS
- Association between Helicobacter pylori infection and nonalcoholic fatty liver disease
- (2019) Longui Ning et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction?
- (2019) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- (2019) Fernando Bril et al. DIABETES CARE
- NAFLD in children: new genes, new diagnostic modalities and new drugs
- (2019) Valerio Nobili et al. Nature Reviews Gastroenterology & Hepatology
- Editorial: The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis due to NASH
- (2019) Rohit Loomba et al. HEPATOLOGY
- In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis
- (2018) Jonathan A. Africa et al. Clinical Gastroenterology and Hepatology
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?
- (2018) Stergios A. Polyzos et al. HEPATOLOGY
- Nonalcoholic Liver Disease in Children and Adolescents
- (2018) Sara Kathryn Smith et al. Clinics in Liver Disease
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Current and future pharmacological therapies for NAFLD/NASH
- (2017) Yoshio Sumida et al. JOURNAL OF GASTROENTEROLOGY
- The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
- (2017) Vasilios G. Athyros et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The pharmacological management of NAFLD in children and adolescents
- (2017) Savinda Liyanagedera et al. Expert Review of Clinical Pharmacology
- Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
- (2016) Yaron Rotman et al. GUT
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Liver transplantation for nonalcoholic steatohepatitis in young patients
- (2016) Naim Alkhouri et al. TRANSPLANT INTERNATIONAL
- Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial
- (2016) Claudia Della Corte et al. PLoS One
- A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease
- (2015) L. Pacifico et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Nonalcoholic Fatty Liver Disease
- (2015) Valerio Nobili et al. JAMA Pediatrics
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance
- (2010) Giovanni Tarantino WORLD JOURNAL OF GASTROENTEROLOGY
- Histopathology of nonalcoholic fatty liver disease
- (2010) Elizabeth M Brunt WORLD JOURNAL OF GASTROENTEROLOGY
- The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years
- (2009) A E Feldstein et al. GUT
- Nonalcoholic steatohepatitis in children: A multicenter clinicopathological study
- (2009) Christine Carter-Kent et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now